[#item_full_content] The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women’s health, Dr. Staci Gruber tells GBH’s All Things Considered. Read More
PSN Briefings
Plain-English cannabis industry updates — what changed, what didn’t, and why it matters.
Episode 1 • Federal Rescheduling — What Actually ChangedLatest PSN Briefs
Short, plain-English updates from the PSN desk
- What federal rescheduling did NOT change
- Why state cannabis boards still control outcomes
- What operators should not assume in 2026